This tool looks for unlabeled Wikidata items in your language. It starts with a Wikidata item,
looks at all the associated Wikipedia pages, the links on all those pages, and lists the Wikidata items corresponding to the link targets.
Q3799026 - No label in !
Searching link targets on 4 Wikipedias...
Item | Label [] | Wikilabels | Link # |
---|---|---|---|
Q249619 [CC | ] | No label in ! | Immunosuppressive drug | Immunosoppressore | دواء كبت مناعة | Thuốc ức chế miễn dịch | 4 |
Q422248 [CC | ] | No label in ! | Monoclonal antibody | Anticorpo monoclonale | ضد وحيد النسيلة | Kháng thể đơn dòng | 4 |
Q348260 [CC | ] | No label in ! | Adalimumab | أداليموماب | 3 |
Q3606143 [CC | ] | No label in ! | Afelimomab | أفيليموماب | 3 |
Q3624931 [CC | ] | No label in ! | Aselizumab | أسيليزوماب | 3 |
Q3629019 [CC | ] | No label in ! | Atorolimumab | أتوروليموماب | 3 |
Q418702 [CC | ] | No label in ! | Basiliximab | باسيليكسيماب | 3 |
Q1996249 [CC | ] | No label in ! | Belimumab | بيليموماب | 3 |
Q4895713 [CC | ] | No label in ! | Bertilimumab | برتيليموماب | 3 |
Q102507 [CC | ] | No label in ! | CAS Registry Number | Numero CAS | رقم التسجيل CAS | 3 |
Q412909 [CC | ] | No label in ! | Certolizumab pegol | سرتوليزوماب بيغول | 3 |
Q3680492 [CC | ] | No label in ! | Clenoliximab | كلينوليكسيماب | 3 |
Q412920 [CC | ] | No label in ! | Daclizumab | داكليزوماب | 3 |
Q421617 [CC | ] | No label in ! | Eculizumab | إيكوليزوماب | 3 |
Q418270 [CC | ] | No label in ! | Efalizumab | إيفاليزوماب | 3 |
Q923443 [CC | ] | No label in ! | Elsilimomab | إلسيليموماب | 3 |
Q3731886 [CC | ] | No label in ! | Erlizumab | إرليزوماب | 3 |
Q3739511 [CC | ] | No label in ! | Faralimomab | فاراليموماب | 3 |
Q3747524 [CC | ] | No label in ! | Fontolizumab | فونتوليزوماب | 3 |
Q425158 [CC | ] | No label in ! | Fusion protein | Proteina di fusione | بروتين اندماجي | 3 |
Q966412 [CC | ] | No label in ! | Galiximab | غاليكسيماب | 3 |
Q3758982 [CC | ] | No label in ! | Gavilimomab | غافيليموماب | 3 |
Q413879 [CC | ] | No label in ! | Golimumab | غوليموماب | 3 |
Q415264 [CC | ] | No label in ! | Infliximab | إنفليكسيماب | 3 |
Q2459042 [CC | ] | No label in ! | Ipilimumab | إيبيليموماب | 3 |
Q3814375 [CC | ] | No label in ! | Keliximab | كيليكسيماب | 3 |
Q3829321 [CC | ] | No label in ! | Lebrikizumab | لبريكيزوماب | 3 |
Q3830773 [CC | ] | No label in ! | Lerdelimumab | لردليموماب | 3 |
Q3840604 [CC | ] | No label in ! | Lumiliximab | لوميليكسيماب | 3 |
Q3850818 [CC | ] | No label in ! | Maslimomab | ماسليموماب | 3 |
Q3306175 [CC | ] | No label in ! | Mepolizumab | ميبوليزوماب | 3 |
Q14605026 [CC | ] | No label in ! | Morolimumab | موروليموماب | 3 |
Q386119 [CC | ] | No label in ! | Natalizumab | ناتاليزوماب | 3 |
Q2013780 [CC | ] | No label in ! | Ocrelizumab | أوكرليزوماب | 3 |
Q415392 [CC | ] | No label in ! | Omalizumab | أوماليزوماب | 3 |
Q7701358 [CC | ] | No label in ! | Teplizumab | تيبليزوماب | 3 |
Q425154 [CC | ] | No label in ! | Tocilizumab | توسيليزوماب | 3 |
Q7918002 [CC | ] | No label in ! | Vedolizumab | فيدوليزوماب | 3 |
Q2697833 [CC | ] | No label in ! | Abatacept | أباتاسيبت | 2 |
Q4689286 [CC | ] | No label in ! | Aflibercept | أفليبيرسيبت | 2 |
Q3609421 [CC | ] | No label in ! | Alefacept | أليفاسبت | 2 |
Q415411 [CC | ] | No label in ! | Anakinra | آناكينرا | 2 |
Q192093 [CC | ] | No label in ! | Anatomical Therapeutic Chemical Classification System | نظام التصنيف الكيميائي العلاجي التشريحي | 2 |
Q15708296 [CC | ] | No label in ! | Anifrolumab | 2 |
Q79460 [CC | ] | No label in ! | Antibody | جسم مضاد | 2 |
Q50573407 [CC | ] | No label in ! | Antifolate | مضاد الفولات | 2 |
Q103537 [CC | ] | No label in ! | Antigen | مولد الضد | 2 |
Q50429865 [CC | ] | No label in ! | Antimetabolite | مضاد المئيضة | 2 |
Q2858961 [CC | ] | No label in ! | Apremilast | أبريميلاست | 2 |
Q20707748 [CC | ] | No label in ! | Atezolizumab | 2 |
Q21083261 [CC | ] | No label in ! | Avelumab | 2 |
Q18939 [CC | ] | No label in ! | Azathioprine | آزاثيوبرين | 2 |
Q810010 [CC | ] | No label in ! | Basigin | باسيجين | 2 |
Q3638304 [CC | ] | No label in ! | Benralizumab | 2 |
Q3644426 [CC | ] | No label in ! | Briakinumab | 2 |
Q14897851 [CC | ] | No label in ! | CD154 | كتلة التمايز 154 | 2 |
Q412587 [CC | ] | No label in ! | CD4 | كتلة التمايز 4 | 2 |
Q21135811 [CC | ] | No label in ! | CD40 (protein) | كتلة التمايز 40 | 2 |
Q5009843 [CC | ] | No label in ! | CD80 | كتلة التمايز 80 | 2 |
Q3655009 [CC | ] | No label in ! | Canakinumab | 2 |
Q5057039 [CC | ] | No label in ! | Cedelizumab | سيديليزوماب | 2 |
Q55606818 [CC | ] | No label in ! | Cemiplimab | 2 |
Q2311683 [CC | ] | No label in ! | ChemSpider | كيم سبايدر | 2 |
Q367700 [CC | ] | No label in ! | Ciclosporin | سيكلوسبورين | 2 |
Q30612 [CC | ] | No label in ! | Clinical trial | Studio clinico | 2 |
Q28209568 [CC | ] | No label in ! | Crizanlizumab | 2 |
Q85757472 [CC | ] | No label in ! | Dostarlimab | 2 |
Q28209889 [CC | ] | No label in ! | Emapalumab | 2 |
Q3730737 [CC | ] | No label in ! | Epratuzumab | 2 |
Q415343 [CC | ] | No label in ! | Etanercept | إيتانرسبت | 2 |
Q5404888 [CC | ] | No label in ! | Etrolizumab | 2 |
Q421052 [CC | ] | No label in ! | Everolimus | إيفيروليموس | 2 |
Q3753116 [CC | ] | No label in ! | Fresolimumab | 2 |
Q5554924 [CC | ] | No label in ! | Gevokizumab | 2 |
Q3773206 [CC | ] | No label in ! | Gomiliximab | 2 |
Q5939625 [CC | ] | No label in ! | Humanized antibody | Anticorpo umanizzato | 2 |
Q5971673 [CC | ] | No label in ! | IL-2 receptor | مستقبل الإنترلوكين-2 | 2 |
Q3791531 [CC | ] | No label in ! | Ibalizumab | 2 |
Q1059 [CC | ] | No label in ! | Immune system | Sistema immunitario | 2 |
Q79455 [CC | ] | No label in ! | Immunoglobulin E | غلوبيولين مناعي هـ | 2 |
Q1455316 [CC | ] | No label in ! | Immunosuppression | تثبيط مناعي | 2 |
Q409715 [CC | ] | No label in ! | Integrin | إنتغرين | 2 |
Q188269 [CC | ] | No label in ! | Interferon | إنترفيرون | 2 |
Q194908 [CC | ] | No label in ! | Interleukin | Interleuchine | 2 |
Q2409681 [CC | ] | No label in ! | Interleukin 12 | إنترلوكين 12 | 2 |
Q99486570 [CC | ] | No label in ! | Interleukin 17 | إنترلوكين 17 | 2 |
Q410130 [CC | ] | No label in ! | Interleukin 2 | إنترلوكين 2 | 2 |
Q412889 [CC | ] | No label in ! | Interleukin 6 | إنترلوكين 6 | 2 |
Q6094826 [CC | ] | No label in ! | Itolizumab | 2 |
Q13574436 [CC | ] | No label in ! | Ixekizumab | 2 |
Q248550 [CC | ] | No label in ! | Leflunomide | ليفلونوميد | 2 |
Q3830104 [CC | ] | No label in ! | Lemalesomab | 2 |
Q425681 [CC | ] | No label in ! | Lenalidomide | ليناليدوميد | 2 |
Q6557650 [CC | ] | No label in ! | Lirilumab | 2 |
Q45248409 [CC | ] | No label in ! | Lokivetmab | 2 |
Q285613 [CC | ] | No label in ! | MTOR | هدف الثدييات من الراباميسين | 2 |
Q422687 [CC | ] | No label in ! | Macrolide | ماكروليد | 2 |
Q6823403 [CC | ] | No label in ! | Metelimumab | ميتيليموماب | 2 |
Q422232 [CC | ] | No label in ! | Methotrexate | ميثوتركسيت | 2 |
Q6890447 [CC | ] | No label in ! | Mogamulizumab | 2 |
Q2751034 [CC | ] | No label in ! | Mouse | فأر | 2 |
Q416494 [CC | ] | No label in ! | Muromonab-CD3 | موروموناب - سي دي 3 | 2 |
Q420553 [CC | ] | No label in ! | Mycophenolic acid | حمض الميكوفينوليك | 2 |
Q6961860 [CC | ] | No label in ! | Namilumab | 2 |
Q6996050 [CC | ] | No label in ! | Nerelimomab | نريليموماب | 2 |
Q7041828 [CC | ] | No label in ! | Nivolumab | 2 |
Q389496 [CC | ] | No label in ! | Obinutuzumab | أوبينوتوزوماب | 2 |
Q7078368 [CC | ] | No label in ! | Odulimomab | أودوليموماب | 2 |
Q47123037 [CC | ] | No label in ! | Oleclumab | 2 |
Q7116652 [CC | ] | No label in ! | Ozoralizumab | 2 |
Q48851069 [CC | ] | No label in ! | Pamrevlumab | 2 |
Q7141848 [CC | ] | No label in ! | Pascolizumab | 2 |
Q13896859 [CC | ] | No label in ! | Pembrolizumab | 2 |
Q7166882 [CC | ] | No label in ! | Perakizumab | 2 |
Q7179565 [CC | ] | No label in ! | Pexelizumab | 2 |
Q7180990 [CC | ] | No label in ! | Phases of clinical research | Fasi della sperimentazione clinica | 2 |
Q7191298 [CC | ] | No label in ! | Pidilizumab | 2 |
Q417489 [CC | ] | No label in ! | Pimecrolimus | بيميكروليموس | 2 |
Q25326699 [CC | ] | No label in ! | Plozalizumab | 2 |
Q930144 [CC | ] | No label in ! | Polyclonal antibodies | ضد متعدد النسائل | 2 |
Q7227206 [CC | ] | No label in ! | Pomalidomide | بوماليدوميد | 2 |
Q7271973 [CC | ] | No label in ! | Quilizumab | 2 |
Q58315670 [CC | ] | No label in ! | Relatlimab | 2 |
Q7315650 [CC | ] | No label in ! | Reslizumab | 2 |
Q2151796 [CC | ] | No label in ! | Ridaforolimus | ريدافورليموس | 2 |
Q7334300 [CC | ] | No label in ! | Rilonacept | ريلوناسيبت | 2 |
Q412323 [CC | ] | No label in ! | Rituximab | ريتوكسيماب | 2 |
Q7366071 [CC | ] | No label in ! | Rontalizumab | 2 |
Q3941929 [CC | ] | No label in ! | Rovelizumab | 2 |
Q7408522 [CC | ] | No label in ! | Samalizumab | 2 |
Q7424081 [CC | ] | No label in ! | Sarilumab | 2 |
Q7444755 [CC | ] | No label in ! | Secukinumab | سيكيوكينيوماب | 2 |
Q7511830 [CC | ] | No label in ! | Sifalimumab | 2 |
Q32089 [CC | ] | No label in ! | Sirolimus | سيروليموس | 2 |
Q7530673 [CC | ] | No label in ! | Sirukumab | 2 |
Q60785560 [CC | ] | No label in ! | Spartalizumab | 2 |
Q111172579 [CC | ] | No label in ! | Spesolimab | 2 |
Q193529 [CC | ] | No label in ! | T cell | خلية تائية | 2 |
Q1536078 [CC | ] | No label in ! | TNF inhibitor | مثبط عامل نخر الورم | 2 |
Q7672878 [CC | ] | No label in ! | Tabalumab | 2 |
Q411648 [CC | ] | No label in ! | Tacrolimus | تاكروليمس | 2 |
Q3976820 [CC | ] | No label in ! | Technetium (99mTc) sulesomab | Sulesomab | 2 |
Q7699074 [CC | ] | No label in ! | Temsirolimus | تيمزيروليموس | 2 |
Q3077133 [CC | ] | No label in ! | Teriflunomide | تيريفلونوميد | 2 |
Q25326702 [CC | ] | No label in ! | Tezepelumab | 2 |
Q203174 [CC | ] | No label in ! | Thalidomide | ثاليدوميد | 2 |
Q15708331 [CC | ] | No label in ! | Tildrakizumab | 2 |
Q7825392 [CC | ] | No label in ! | Toralizumab | 2 |
Q7837825 [CC | ] | No label in ! | Tregalizumab | 2 |
Q21098907 [CC | ] | No label in ! | Ulocuplumab | 2 |
Q6593799 [CC | ] | No label in ! | Unique Ingredient Identifier | معرف المكون الفريد | 2 |
Q420305 [CC | ] | No label in ! | Ustekinumab | 2 |
Q7920695 [CC | ] | No label in ! | Vepalimomab | 2 |
Q7936102 [CC | ] | No label in ! | Visilizumab | 2 |
Q25326713 [CC | ] | No label in ! | Vobarilizumab | 2 |
Q8066254 [CC | ] | No label in ! | Zanolimumab | 2 |
Q25670 [CC | ] | No label in ! | Digital object identifier | معرف الغرض الرقمي | 2 |
Q1122544 [CC | ] | No label in ! | DrugBank | درغ بنك | 2 |
Q434115 [CC | ] | No label in ! | ATC code L04 | 1 |
Q4667244 [CC | ] | No label in ! | Abetimus | 1 |
Q19903170 [CC | ] | No label in ! | Abrilumab | 1 |
Q420164 [CC | ] | No label in ! | Alemtuzumab | 1 |
Q48975957 [CC | ] | No label in ! | Andecaliximab | 1 |
Q3458624 [CC | ] | No label in ! | Anrukinzumab | 1 |
Q4774393 [CC | ] | No label in ! | Anti-lymphocyte globulin | 1 |
Q584065 [CC | ] | No label in ! | Anti-thymocyte globulin | 1 |
Q4780240 [CC | ] | No label in ! | Apolizumab | 1 |
Q27285470 [CC | ] | No label in ! | Avacopan | 1 |
Q4860707 [CC | ] | No label in ! | Baricitinib | 1 |
Q4881990 [CC | ] | No label in ! | Belatacept | 1 |
Q30314044 [CC | ] | No label in ! | Bermekimab | 1 |
Q1871058 [CC | ] | No label in ! | Besilesomab | 1 |
Q60785566 [CC | ] | No label in ! | Bimekizumab | 1 |
Q48850555 [CC | ] | No label in ! | Bleselumab | 1 |
Q4926814 [CC | ] | No label in ! | Blisibimod | 1 |
Q28209015 [CC | ] | No label in ! | Brazikumab | 1 |
Q4972934 [CC | ] | No label in ! | Brodalumab | 1 |
Q5009796 [CC | ] | No label in ! | CD20 | 1 |
Q4845302 [CC | ] | No label in ! | CD23 | 1 |
Q419458 [CC | ] | No label in ! | CD3 (immunology) | 1 |
Q420566 [CC | ] | No label in ! | Calcineurin | 1 |
Q55606493 [CC | ] | No label in ! | Camidanlumab tesirine | 1 |
Q60785565 [CC | ] | No label in ! | Camrelizumab | 1 |
Q5043094 [CC | ] | No label in ! | Carlumab | 1 |
Q24744759 [CC | ] | No label in ! | Chloramphenicol acetyltransferase | 1 |
Q3601001 [CC | ] | No label in ! | Clazakizumab | 1 |
Q5148523 [CC | ] | No label in ! | Colony stimulating factor 1 receptor | 1 |
Q426181 [CC | ] | No label in ! | Complement component 5 | 1 |
Q123574195 [CC | ] | No label in ! | Crovalimab | 1 |
Q3774751 [CC | ] | No label in ! | Cyclophilin | 1 |
Q124407181 [CC | ] | No label in ! | Danicopan | 1 |
Q1187179 [CC | ] | No label in ! | Denileukin diftitox | 1 |
Q113940477 [CC | ] | No label in ! | Deucravacitinib | 1 |
Q1150909 [CC | ] | No label in ! | Dihydroorotate dehydrogenase | 1 |
Q5315925 [CC | ] | No label in ! | Dupilumab | 1 |
Q19904005 [CC | ] | No label in ! | Durvalumab | 1 |
Q123699809 [CC | ] | No label in ! | Efavaleukin alfa | 1 |
Q110271677 [CC | ] | No label in ! | Efgartigimod alfa | 1 |
Q120487796 [CC | ] | No label in ! | Efgartigimod alfa/hyaluronidase | 1 |
Q10423561 [CC | ] | No label in ! | Eldelumab | 1 |
Q27265630 [CC | ] | No label in ! | Etrasimod | 1 |
Q583864 [CC | ] | No label in ! | FKBP | 1 |
Q5446179 [CC | ] | No label in ! | Fezakinumab | 1 |
Q19904163 [CC | ] | No label in ! | Filgotinib | 1 |
Q425137 [CC | ] | No label in ! | Fingolimod | 1 |
Q19904185 [CC | ] | No label in ! | Fletikumab | 1 |
Q123162030 [CC | ] | No label in ! | Frexalimab | 1 |
Q1194520 [CC | ] | No label in ! | Graft-versus-host disease | 1 |
Q15708315 [CC | ] | No label in ! | Guselkumab | 1 |
Q10910504 [CC | ] | No label in ! | Gusperimus | 1 |
Q18035000 [CC | ] | No label in ! | IL18BP | 1 |
Q18045083 [CC | ] | No label in ! | IL22RA1 | 1 |
Q18038696 [CC | ] | No label in ! | IL36A | 1 |
Q18038694 [CC | ] | No label in ! | IL36B | 1 |
Q5971720 [CC | ] | No label in ! | IL36G | 1 |
Q60785567 [CC | ] | No label in ! | Ianalumab | 1 |
Q1660194 [CC | ] | No label in ! | Immunomodulator | 1 |
Q25326696 [CC | ] | No label in ! | Inebilizumab | 1 |
Q411529 [CC | ] | No label in ! | Interleukin 1 beta | 1 |
Q423698 [CC | ] | No label in ! | Interleukin 10 | 1 |
Q18027860 [CC | ] | No label in ! | Interleukin 10 receptor, beta subunit | 1 |
Q14906031 [CC | ] | No label in ! | Interleukin 11 | 1 |
Q14878303 [CC | ] | No label in ! | Interleukin 13 | 1 |
Q3799484 [CC | ] | No label in ! | Interleukin 14 | 1 |
Q14907167 [CC | ] | No label in ! | Interleukin 15 | 1 |
Q14907199 [CC | ] | No label in ! | Interleukin 16 | 1 |
Q14907187 [CC | ] | No label in ! | Interleukin 18 | 1 |
Q18039723 [CC | ] | No label in ! | Interleukin 19 | 1 |
Q18039820 [CC | ] | No label in ! | Interleukin 20 | 1 |
Q18040694 [CC | ] | No label in ! | Interleukin 20 receptor, alpha subunit | 1 |
Q18040697 [CC | ] | No label in ! | Interleukin 20 receptor, beta subunit | 1 |
Q909381 [CC | ] | No label in ! | Interleukin 21 | 1 |
Q14907275 [CC | ] | No label in ! | Interleukin 22 | 1 |
Q23308590 [CC | ] | No label in ! | Interleukin 23 | 1 |
Q14907265 [CC | ] | No label in ! | Interleukin 24 | 1 |
Q14907245 [CC | ] | No label in ! | Interleukin 26 | 1 |
Q50263416 [CC | ] | No label in ! | Interleukin 27 | 1 |
Q24787633 [CC | ] | No label in ! | Interleukin 28 | 1 |
Q14907239 [CC | ] | No label in ! | Interleukin 29 | 1 |
Q14866169 [CC | ] | No label in ! | Interleukin 3 | 1 |
Q14907226 [CC | ] | No label in ! | Interleukin 31 | 1 |
Q18033933 [CC | ] | No label in ! | Interleukin 32 | 1 |
Q18048437 [CC | ] | No label in ! | Interleukin 33 | 1 |
Q18051459 [CC | ] | No label in ! | Interleukin 34 | 1 |
Q6047058 [CC | ] | No label in ! | Interleukin 35 | 1 |
Q17042100 [CC | ] | No label in ! | Interleukin 36 | 1 |
Q18038281 [CC | ] | No label in ! | Interleukin 36 receptor antagonist | 1 |
Q18038695 [CC | ] | No label in ! | Interleukin 37 | 1 |
Q118368435 [CC | ] | No label in ! | Interleukin 4 | 1 |
Q14877650 [CC | ] | No label in ! | Interleukin 5 | 1 |
Q14889532 [CC | ] | No label in ! | Interleukin 7 | 1 |
Q14874544 [CC | ] | No label in ! | Interleukin 9 | 1 |
Q3931286 [CC | ] | No label in ! | Interleukin receptor | 1 |
Q15996698 [CC | ] | No label in ! | Interleukin-1 receptor | 1 |
Q6046902 [CC | ] | No label in ! | Interleukin-10 receptor | 1 |
Q6046900 [CC | ] | No label in ! | Interleukin-11 receptor | 1 |
Q6046905 [CC | ] | No label in ! | Interleukin-12 receptor | 1 |
Q6046910 [CC | ] | No label in ! | Interleukin-13 receptor | 1 |
Q27312158 [CC | ] | No label in ! | Interleukin-15 receptor | 1 |
Q6046916 [CC | ] | No label in ! | Interleukin-17 receptor | 1 |
Q6046920 [CC | ] | No label in ! | Interleukin-18 receptor | 1 |
Q50263517 [CC | ] | No label in ! | Interleukin-20 receptor | 1 |
Q18039826 [CC | ] | No label in ! | Interleukin-21 receptor | 1 |
Q15996700 [CC | ] | No label in ! | Interleukin-22 receptor | 1 |
Q18051880 [CC | ] | No label in ! | Interleukin-23 receptor | 1 |
Q50263420 [CC | ] | No label in ! | Interleukin-27 receptor | 1 |
Q6046936 [CC | ] | No label in ! | Interleukin-28 receptor | 1 |
Q21116062 [CC | ] | No label in ! | Interleukin-3 receptor | 1 |
Q25106490 [CC | ] | No label in ! | Interleukin-31 receptor | 1 |
Q18027830 [CC | ] | No label in ! | Interleukin-4 receptor | 1 |
Q15996702 [CC | ] | No label in ! | Interleukin-5 receptor | 1 |
Q18027836 [CC | ] | No label in ! | Interleukin-6 receptor | 1 |
Q6046964 [CC | ] | No label in ! | Interleukin-7 receptor | 1 |
Q24719789 [CC | ] | No label in ! | Interleukin-8 receptor | 1 |
Q76803684 [CC | ] | No label in ! | Iptacopan | 1 |
Q903451 [CC | ] | No label in ! | Janus kinase | 1 |
Q4042403 [CC | ] | No label in ! | L-selectin | 1 |
Q6482369 [CC | ] | No label in ! | Lampalizumab | 1 |
Q25326708 [CC | ] | No label in ! | Lanadelumab | 1 |
Q25326692 [CC | ] | No label in ! | Lenzilumab | 1 |
Q827023 [CC | ] | No label in ! | Lesion | 1 |
Q48850536 [CC | ] | No label in ! | Letolizumab | 1 |
Q123385235 [CC | ] | No label in ! | Levilimab | 1 |
Q6545898 [CC | ] | No label in ! | Ligelizumab | 1 |
Q104178616 [CC | ] | No label in ! | Lirentelimab | 1 |
Q217094 [CC | ] | No label in ! | List of withdrawn drugs | 1 |
Q20706900 [CC | ] | No label in ! | Lulizumab pegol | 1 |
Q4042438 [CC | ] | No label in ! | Lymphocyte function-associated antigen 1 | 1 |
Q6794291 [CC | ] | No label in ! | Mavrilimumab | 1 |
Q55641096 [CC | ] | No label in ! | Mirikizumab | 1 |
Q111370719 [CC | ] | No label in ! | Nivolumab/relatlimab | 1 |
Q410656 [CC | ] | No label in ! | Ofatumumab | 1 |
Q7088501 [CC | ] | No label in ! | Olokizumab | 1 |
Q7098691 [CC | ] | No label in ! | Oprelvekin | 1 |
Q7108506 [CC | ] | No label in ! | Otelixizumab | 1 |
Q7115169 [CC | ] | No label in ! | Oxelumab | 1 |
Q21098986 [CC | ] | No label in ! | Ozanimod | 1 |
Q7144397 [CC | ] | No label in ! | Pateclizumab | 1 |
Q27088288 [CC | ] | No label in ! | Peficitinib | 1 |
Q106863504 [CC | ] | No label in ! | Pegcetacoplan | 1 |
Q7199029 [CC | ] | No label in ! | Pitrakinra | 1 |
Q7200426 [CC | ] | No label in ! | Placulumab | 1 |
Q18604129 [CC | ] | No label in ! | Ponesimod | 1 |
Q7242994 [CC | ] | No label in ! | Priliximab | 1 |
Q17037731 [CC | ] | No label in ! | Promegapoietin | 1 |
Q55641547 [CC | ] | No label in ! | Ravulizumab | 1 |
Q25098750 [CC | ] | No label in ! | Receptor modulator | 1 |
Q117349369 [CC | ] | No label in ! | Retifanlimab | 1 |
Q25112466 [CC | ] | No label in ! | Risankizumab | 1 |
Q120487896 [CC | ] | No label in ! | Ritlecitinib | 1 |
Q120491843 [CC | ] | No label in ! | Rozanolixizumab | 1 |
Q7380420 [CC | ] | No label in ! | Ruplizumab | 1 |
Q58218746 [CC | ] | No label in ! | Satralizumab | 1 |
Q3960572 [CC | ] | No label in ! | Siltuximab | 1 |
Q7525805 [CC | ] | No label in ! | Siplizumab | 1 |
Q25100876 [CC | ] | No label in ! | Siponimod | 1 |
Q60785670 [CC | ] | No label in ! | Sutimlimab | 1 |
Q7679593 [CC | ] | No label in ! | Talizumab | 1 |
Q7692226 [CC | ] | No label in ! | Technetium (99mTc) fanolesomab | 1 |
Q113366205 [CC | ] | No label in ! | Teclistamab | 1 |
Q7697277 [CC | ] | No label in ! | Telimomab aritox | 1 |
Q7699688 [CC | ] | No label in ! | Teneliximab | 1 |
Q7701391 [CC | ] | No label in ! | Teprotumumab | 1 |
Q28209583 [CC | ] | No label in ! | Tislelizumab | 1 |
Q3530324 [CC | ] | No label in ! | Tofacitinib | 1 |
Q7833105 [CC | ] | No label in ! | Tralokinumab | 1 |
Q7838098 [CC | ] | No label in ! | Tremelimumab | 1 |
Q4000172 [CC | ] | No label in ! | Tucotuzumab celmoleukin | 1 |
Q7876570 [CC | ] | No label in ! | Ublituximab | 1 |
Q7881588 [CC | ] | No label in ! | Umirolimus | 1 |
Q27074125 [CC | ] | No label in ! | Upadacitinib | 1 |
Q7900382 [CC | ] | No label in ! | Urelumab | 1 |
Q7915305 [CC | ] | No label in ! | Vapaliximab | 1 |
Q21098904 [CC | ] | No label in ! | Varlilumab | 1 |
Q7917100 [CC | ] | No label in ! | Vatelizumab | 1 |
Q7939256 [CC | ] | No label in ! | Voclosporin | 1 |
Q37155 [CC | ] | No label in ! | WHO Model List of Essential Medicines | 1 |
Q8073564 [CC | ] | No label in ! | Zolimomab aritox | 1 |
Q15410168 [CC | ] | No label in ! | Zotarolimus | 1 |
Q3714304 [CC | ] | No label in ! | Dorlixizumab | 1 |
Q33057 [CC | ] | No label in ! | ISBN | 1 |
Q17633013 [CC | ] | No label in ! | Immunodepressione | 1 |
Q30314619 [CC | ] | No label in ! | Nemolizumab | 1 |
Q2082879 [CC | ] | No label in ! | PMID | 1 |
Q123397307 [CC | ] | No label in ! | Toripalimab | 1 |
Q4893563 [CC | ] | No label in ! | أيض البايريميدين | 1 |
Q3780159 [CC | ] | No label in ! | أيض البيورين | 1 |
Q180686 [CC | ] | No label in ! | ببمد | 1 |
Q229883 [CC | ] | No label in ! | ببمد سنترال | 1 |
Q2907609 [CC | ] | No label in ! | بروتين مرتبط بالخلايا اللمفاوية التائية السامة 4 | 1 |
Q17145978 [CC | ] | No label in ! | دواء إيميدي معدل للمناعة | 1 |
Q614304 [CC | ] | No label in ! | صيدلة | 1 |
Q1427096 [CC | ] | No label in ! | علاج مناعي | 1 |
Q1653297 [CC | ] | No label in ! | قائمة الأجسام المضادة وحيدة النسيلة | 1 |
Q12617752 [CC | ] | No label in ! | Chuột | 1 |
Q123992398 [CC | ] | No label in ! | Chuột nhắt | 1 |